Highlights and Quick Summary
- Operating CF/Net income for the quarter ending December 31, 2022 was 0.69 (a -78.65% decrease compared to previous quarter)
- Year-over-year quarterly Operating CF/Net income decreased by -28.84%
- Annual Operating CF/Net income for 2022 was -2.3 (a -479.61% decrease from previous year)
- Annual Operating CF/Net income for 2021 was 0.61 (a 33.96% increase from previous year)
- Annual Operating CF/Net income for 2020 was 0.45 (a 7.11% increase from previous year)
- Twelve month Operating CF/Net income ending December 31, 2022 was 0.98 (a 5.62% increase compared to previous quarter)
- Twelve month trailing Operating CF/Net income increased by 58.49% year-over-year
Trailing Operating CF/Net income for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| 0.98 | 0.93 | 0.63 | 0.62 |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Operating CF/Net income of Precigen, Inc.
Most recent Operating CF/Net incomeof PGEN including historical data for past 10 years.Interactive Chart of Operating CF/Net income of Precigen, Inc.
Precigen, Inc. Operating CF/Net income for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | 0.69 | 3.25 | 0.4 | 0.98 | -2.3 |
| 2021 | 0.58 | 0.57 | 0.39 | 0.95 | 0.61 |
| 2020 | 0.4 | 0.64 | 0.32 | 0.5 | 0.45 |
| 2019 | 0.19 | 0.51 | 0.86 | 0.71 | 0.42 |
| 2018 | 0.11 | 0.5 | 0.43 | 0.65 | 0.24 |
| 2017 | 1.24 | 0.55 | 1.24 | 0.79 | 0.89 |
| 2016 | 0.39 | 0.54 | 0.25 | 0.06 | 0.26 |
| 2015 | -0.38 | -1.38 | 0.41 | -0.48 | -0.42 |
| 2014 | -0.48 | 0.13 | 0.26 | 2.3 | 0.24 |
| 2013 | 1.13 | -1.9 | 0.96 | 0.33 | 0.94 |
| 2012 | 0.0 | 0.59 | 1.55 | – | 0.59 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology